Literature DB >> 29978358

Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer: Trends and Controversies.

Amol K Narang1, Jeffrey Meyer2.   

Abstract

PURPOSE OF REVIEW: For patients with locally advanced rectal cancer, neoadjuvant hypofractionated short-course radiation remains an underutilized regimen in the USA. We review the current clinical literature highlighting the relative merits of short-course radiation, along with modern neoadjuvant strategies that incorporate its use. RECENT
FINDINGS: As compared to long-course chemoradiation with delayed surgery, short-course radiation with early surgery offers similar oncologic efficacy for locally advanced rectal cancer patients. Delaying surgery after short-course radiation decreases post-operative complications as compared to early surgery and improves tumor downstaging. Delaying surgery also offers the opportunity to administer neoadjuvant systemic therapy, which may help increase local-regional tumor response and potentially decrease distant relapse rates, the latter a persisting problem in rectal cancer treatment. Short-course radiation, either with immediate or with delayed surgery, represents an appealing treatment alternative to long-course chemoradiation for patients with locally advanced rectal cancer.

Entities:  

Keywords:  Hypofractionated radiation; Neoadjuvant radiation; Rectal cancer; Short-course radiation; Total neoadjuvant therapy

Mesh:

Year:  2018        PMID: 29978358     DOI: 10.1007/s11912-018-0714-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  37 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.

Authors:  Joakim Folkesson; Helgi Birgisson; Lars Pahlman; Bjorn Cedermark; Bengt Glimelius; Ulf Gunnarsson
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

3.  Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.

Authors:  Deborah Schrag; Martin R Weiser; Karyn A Goodman; Mithat Gonen; Ellen Hollywood; Andrea Cercek; Diane L Reidy-Lagunes; Marc J Gollub; Jinru Shia; Jose G Guillem; Larissa K F Temple; Philip B Paty; Leonard B Saltz
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

4.  Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.

Authors:  Corrie A M Marijnen; Cornelis J H van de Velde; Hein Putter; Mandy van den Brink; Cornelis P Maas; Hendrik Martijn; Harm J Rutten; Theo Wiggers; Elma Klein Kranenbarg; Jan-Willem H Leer; Anne M Stiggelbout
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

5.  Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.

Authors:  Stephanie Markovina; Fady Youssef; Amit Roy; Sonya Aggarwal; Shariq Khwaja; Todd DeWees; Benjamin Tan; Steven Hunt; Robert J Myerson; Daniel T Chang; Parag J Parikh; Jeffrey R Olsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-06       Impact factor: 7.038

6.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

Authors:  Jean-Pierre Gérard; David Azria; Sophie Gourgou-Bourgade; Isabelle Martel-Lafay; Christophe Hennequin; Pierre-Luc Etienne; Véronique Vendrely; Eric François; Guy de La Roche; Olivier Bouché; Xavier Mirabel; Bernard Denis; Laurent Mineur; Jean-François Berdah; Marc-André Mahé; Yves Bécouarn; Olivier Dupuis; Gérard Lledo; Jean-François Seitz; Laurent Bedenne; Béata Juzyna; Thierry Conroy
Journal:  J Clin Oncol       Date:  2012-10-29       Impact factor: 44.544

7.  Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial.

Authors:  Carlos Fernandez-Martos; Gina Brown; Rafael Estevan; Antonieta Salud; Clara Montagut; Joan Maurel; Maria Jose Safont; Jorge Aparicio; Jaime Feliu; Ruth Vera; Vicente Alonso; Javier Gallego; Marta Martin; Miguel Pera; Enrique Sierra; Javier Serra; Salvadora Delgado; Jose V Roig; Jesus Santos; Carles Pericay
Journal:  Oncologist       Date:  2014-09-10

8.  Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial.

Authors: 
Journal:  Br J Surg       Date:  1993-10       Impact factor: 6.939

9.  Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy.

Authors:  H Birgisson; L Påhlman; U Gunnarsson; B Glimelius
Journal:  Br J Surg       Date:  2008-02       Impact factor: 6.939

10.  Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.

Authors:  Per J Nilsson; Boudewijn van Etten; Geke A P Hospers; Lars Påhlman; Cornelis J H van de Velde; Regina G H Beets-Tan; Lennart Blomqvist; Jannet C Beukema; Ellen Kapiteijn; Corrie A M Marijnen; Iris D Nagtegaal; Theo Wiggers; Bengt Glimelius
Journal:  BMC Cancer       Date:  2013-06-07       Impact factor: 4.430

View more
  2 in total

1.  Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis.

Authors:  Wang Qiaoli; Huang Yongping; Xiong Wei; Xu Guoqiang; Ju Yunhe; Liu Qiuyan; Li Cheng; Guo Mengling; Li Jiayi; Xiong Wei; Yang Yi
Journal:  Int J Colorectal Dis       Date:  2019-11-19       Impact factor: 2.571

2.  Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation.

Authors:  Margaret M Kozak; Diego A S Toesca; Rie von Eyben; Erqi L Pollom; Daniel T Chang
Journal:  Adv Radiat Oncol       Date:  2019-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.